Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.

Boyce BF, Schwarz EM, Xing L.

Curr Opin Rheumatol. 2006 Jul;18(4):427-32. Review.

PMID:
16763465
2.

Osteoclast precursors, RANKL/RANK, and immunology.

Xing L, Schwarz EM, Boyce BF.

Immunol Rev. 2005 Dec;208:19-29. Review.

PMID:
16313338
3.
4.

TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood.

Zhang Q, Guo R, Schwarz EM, Boyce BF, Xing L.

Arthritis Res Ther. 2008;10(2):R37. doi: 10.1186/ar2391. Epub 2008 Mar 27.

5.

Regulation of osteoclast precursors in inflammatory bone loss.

Xing L.

Curr Opin Investig Drugs. 2009 Nov;10(11):1195-203. Review.

PMID:
19876787
6.

Autoimmunity and bone.

Schwarz EM, Looney RJ, Drissi MH, O'Keefe RJ, Boyce BF, Xing L, Ritchlin CT.

Ann N Y Acad Sci. 2006 Apr;1068:275-83.

PMID:
16831928
7.

Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L.

Arthritis Rheum. 2004 Jan;50(1):265-76.

8.

NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.

Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF.

J Biol Chem. 2007 Jun 22;282(25):18245-53. Epub 2007 May 7.

9.

Increased lymphangiogenesis in joints of mice with inflammatory arthritis.

Zhang Q, Lu Y, Proulx ST, Guo R, Yao Z, Schwarz EM, Boyce BF, Xing L.

Arthritis Res Ther. 2007;9(6):R118.

11.

Bone and joint destruction in rheumatoid arthritis: what is really happening?

Goldring SR.

J Rheumatol Suppl. 2002 Sep;65:44-8. Review. Erratum in: J Rheumatol Suppl. 2002 Nov;29(11):2471.

PMID:
12236623
12.

Cellular and molecular interactions between immune system and bone.

Grcević D, Katavić V, Lukić IK, Kovacić N, Lorenzo JA, Marusić A.

Croat Med J. 2001 Aug;42(4):384-92. Review.

13.

Roles for NF-kappaB and c-Fos in osteoclasts.

Boyce BF, Yamashita T, Yao Z, Zhang Q, Li F, Xing L.

J Bone Miner Metab. 2005;23 Suppl:11-5. Review.

PMID:
15984408
14.

Osteoclast culture and resorption assays.

Bradley EW, Oursler MJ.

Methods Mol Biol. 2008;455:19-35. doi: 10.1007/978-1-59745-104-8_2.

PMID:
18463808
17.

Cytokines regulating osteoclast formation and function.

Lee SK, Lorenzo J.

Curr Opin Rheumatol. 2006 Jul;18(4):411-8. Review.

PMID:
16763463
18.
19.

Osteoclast differentiation and gene regulation.

Zhao Q, Shao J, Chen W, Li YP.

Front Biosci. 2007 Jan 1;12:2519-29. Review.

PMID:
17127260
20.

Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines.

Speziani C, Rivollier A, Gallois A, Coury F, Mazzorana M, Azocar O, Flacher M, Bella C, Tebib J, Jurdic P, Rabourdin-Combe C, Delprat C.

Eur J Immunol. 2007 Mar;37(3):747-57.

Supplemental Content

Support Center